Detalhe da pesquisa
1.
Factors influencing older women's decision-making related to treatment of operable breast cancer: A qualitative systematic review.
Psychooncology
; 33(1): e6294, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38282220
2.
The Association Between Medication Use in Older Women with Early-Stage Operable Primary Breast Cancer and Decision Regarding Primary Treatment.
Oncologist
; 28(3): e128-e135, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36718086
3.
Oncoplastic breast surgery in older women with primary breast cancer: systematic review.
Br J Surg
; 110(10): 1309-1315, 2023 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310128
4.
Revisiting primary endocrine therapy versus surgery in older women with breast cancer: meta-analysis.
Br J Surg
; 110(4): 420-431, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36718056
5.
Immediate breast reconstruction uptake in older women with primary breast cancer: systematic review.
Br J Surg
; 109(11): 1063-1072, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35909248
6.
Concordance between core needle biopsy and surgical excision specimens for Ki-67 in breast cancer - a systematic review of the literature.
Histopathology
; 80(3): 468-484, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473381
7.
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer.
Cost Eff Resour Alloc
; 20(1): 9, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232445
8.
The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression.
Health Qual Life Outcomes
; 20(1): 169, 2022 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564800
9.
Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative.
Lancet Oncol
; 22(1): e29-e36, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387502
10.
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).
Lancet Oncol
; 22(7): e327-e340, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000244
11.
Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer.
Br J Cancer
; 125(2): 209-219, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972747
12.
Tumour boards in geriatric oncology.
Age Ageing
; 47(2): 168-170, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29145553
13.
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Lancet
; 388(10063): 2997-3005, 2016 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27908454
14.
Construction of tissue microarrays from core needle biopsies - a systematic literature review.
Histopathology
; 68(3): 323-32, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26266325
15.
The balance of clinician and patient input into treatment decision-making in older women with operable breast cancer.
Psychooncology
; 24(12): 1761-6, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26043439
16.
The role of primary endocrine therapy in older women with operable breast cancer.
Future Oncol
; 11(10): 1555-65, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25963432
17.
Patient pathway for breast cancer: turning points and future aspirations.
Future Oncol
; 11(7): 1059-70, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25804121
18.
Primary breast cancer in the elderly: a systematic literature review on histological type and clinical outcome.
Future Oncol
; 11(2): 259-65, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25591838
19.
A competing risk analysis of hormone therapy interruption in Asian women with breast cancer.
Pharmacoepidemiol Drug Saf
; 24(3): 301-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25504903
20.
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.
Lancet Oncol
; 14(10): 989-98, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23902874